When You Can’t Tolerate Antidepressant Side Effects, You Have Not Run Out of Options

The fog was the one that ended it. You read the same work email four times and never answered it.

Before that it was weight you did not choose, and before that a sex life that went flat. Every trial started the same way: a hopeful first week, a rough second, then the thing you could not carry.

So you stopped, and never called to explain why. If treatment costs more than the illness, why keep paying.

If you can’t tolerate antidepressant side effects, that is a clinical finding. It should change what gets tried next.

If you are in crisis or thinking about harming yourself, call or text 988 to reach the Suicide & Crisis Lifeline, or call our Fort Worth office at 817-659-7344.

Why so many medication trials end before they can work

Part of this is arithmetic. The National Institute of Mental Health says antidepressants usually take four to eight weeks to work, and that sleep, appetite, energy and concentration often improve before mood lifts. Side effects do not keep that schedule. They arrive first, so you pay for weeks and collect none of the return.

What a prescriber can adjust when you can’t tolerate antidepressant side effects

None of these are moves to make on your own.

• Separate the effects that settle from the ones that will not. Some ease as the body adjusts; some never do. Telling them apart is a clinical judgment.
• Adjust the amount, the timing, or the form. Tolerability often tracks with how much you take and when. Only your prescriber should change that.
• Change the medication. The 2022 VA/DoD Clinical Practice Guideline says a review of the evidence “was unable to determine a difference in risks of adverse effects that would inform choice” among common first-line antidepressants, and STAR*D, the NIH-funded trial reported in 2006, found no significant tolerability difference among three switch options. Nothing predicts which one you will tolerate, but effects differ sharply between drugs, so switching is a real move.
• Look again at the diagnosis. There is a reason sertraline’s labeling tells prescribers to screen for bipolar disorder before anyone starts: in someone who has it, an antidepressant working with no mood stabilizer beside it can drive mood up into mania or hypomania, and that changes the whole plan. If nobody has asked about stretches of elevated or irritable mood, or nights of far less sleep you did not miss, raise it yourself.
• Consider something that is not a medication. That same guideline counts tolerability of prior treatments among the factors shaping what comes next, though read closely: its phrase “a poor response or intolerable side effects to multiple antidepressants” sits under electroconvulsive therapy, while its TMS suggestion is for partial or no response after two or more adequate trials. Whether trials that ended early count as adequate is your prescriber’s judgment.

Two things not to do

Do not stop abruptly. A 2024 meta-analysis in The Lancet Psychiatry of 79 studies and 21,002 patients found at least one discontinuation symptom in 31 percent of people who stopped an antidepressant versus 17 percent who stopped placebo, and severe symptoms in 2.8 percent against 0.6 percent. Not cause for alarm, but the body adapts, and unwinding that deserves a plan.

Do not push through in silence either. NIMH says to call a provider right away if a medication causes problems. Antidepressants carry an FDA boxed warning that they increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies, a group NIMH describes as children, teenagers and young adults under 25. NIMH says the risk is highest in the first weeks after starting or a dose change, and that all ages need close watching early on. If new or worsening thoughts of harming yourself show up on a medication, call your prescriber now, or 988, or 911.

Antidepressant sexual side effects, said plainly

Lower sex drive, difficulty getting or keeping an erection, delayed or absent ejaculation, and delayed or absent orgasm are recognized antidepressant effects. MedlinePlus lists them in similar words, and FDA labeling for sertraline names ejaculation failure and decreased libido among its most common adverse reactions.

In a 2001 study of 1,022 outpatients in the Journal of Clinical Psychiatry, 59.1 percent had sexual dysfunction and about 40 percent tolerated it poorly, with rates running from about 8 percent on nefazodone and 24 percent on mirtazapine to roughly 71 percent on paroxetine and 73 percent on citalopram, and a 2002 review in Annals of Pharmacotherapy put the SSRI figure at 30 to 60 percent. That study enrolled only people with normal baseline function, some of its agents are not marketed here, and it used a questionnaire rather than waiting for volunteers. What gets counted depends on whether anyone asks, so we ask.

Depression itself affects sexual function too, a two-way relationship described in a 2014 review in Expert Opinion on Drug Safety, and sorting out which is which is a clinical question.

Antidepressant weight gain is a real reason to change the plan

Weight change is not vanity. FDA labeling for mirtazapine names increased appetite and weight gain among its most common adverse reactions, and antidepressants differ in how often this happens, though nobody can predict which one will do it to you. If weight made a medication unlivable, say so at the appointment.

Emotional blunting: when antidepressants make you feel numb

Some people are not more depressed on a medication. They are less of everything. The grief is muted and so is the pleasure.

A 2023 scoping review of 25 studies in Human Psychopharmacology found emotional blunting to be a significant patient-reported concern, and a 2023 qualitative synthesis in the Journal of Psychiatric and Mental Health Nursing records participants calling themselves “dulled,” “numbed” and “flattened.”

A 2023 systematic review in Acta Neuropsychiatrica reports antidepressant-induced apathy between 5.8 and 50 percent, and between 20 and 92 percent for SSRIs. Ranges that wide mean the studies are measuring different things, and a 2021 review in Frontiers in Psychiatry calls antidepressant-induced emotional blunting “largely unexplored.” Whether blunting comes from the medication or from the depression we are treating is unresolved. Raise it anyway.

Where TMS fits when side effects are the problem

Our TMS program uses the FDA-cleared BrainsWay Deep TMS system: focused magnetic pulses through a coil in a cushioned helmet. For devices the FDA word is cleared, not approved. The cleared indication covers “depressive episodes in adult patients suffering from Major Depressive Disorder who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode.” That clearance is for depression; TMS for anxiety, PTSD, bipolar depression or chronic pain is off-label. That indication is built around not getting satisfactory improvement, not around intolerable side effects, though the two often overlap.

TMS belongs here because nothing is swallowed and nothing circulates. The risks FDA identified for this hardware in its classification review include scalp discomfort, dizziness, nausea, pain in the neck or jaw, headache, thermal injury, adverse tissue reaction, hearing loss, and seizure. Weight change and sexual dysfunction are not on that list. That is not a measured comparison, and not a claim that TMS works better than medication: no studies we know of measure either as a TMS outcome, so the honest phrasing is “not a recognized side effect,” not “ruled out.”

TMS is not side-effect free. The VA/DoD guideline names irritation at the stimulation site and headache as its most common adverse events, and suggests TMS after two or more inadequate medication trials, weakly, with very low confidence in the evidence.

Seizure is rare but real, and the rate differs by device. A 2021 survey of Clinical TMS Society members in Brain Stimulation counted 18 seizures across 586,656 sessions in 25,526 patients, with 5.56 per 1,000 patients for the BrainsWay H-coil we use against 0.14 per 1,000 for the most widely used figure-8 devices. The absolute risk is low either way, and the authors called this a voluntary survey that warrants better prospective study.

Labeling also urges caution with any seizure history or anything that could lower the seizure threshold, rules out conductive, ferromagnetic or magnetic-sensitive metal implanted in the head or within 30 cm of the coil, requires earplugs rated for at least 30 dB, and states that long-term effects are unknown. Whether an implant rules you out is a screening question, not a self-assessment; we screen for all of it, and who is a good candidate for TMS covers it.

We are self-pay: TMS is listed at $250 to $450 per session depending on protocol, as of publication, and accelerated protocols involve more sessions. Ask what a full course would cost and check the current Price List.

Frequently asked questions

I quit an antidepressant because of side effects. Does that mean I failed treatment?
No. That medication was not tolerable for you, which is information about the drug and about your body. The 2022 VA/DoD depression guideline counts tolerability of prior treatments among the factors shaping what gets tried next. Bring it to your prescriber.

Can I just stop the medication that is causing this?
Not on your own, and not abruptly. A 2024 Lancet Psychiatry meta-analysis of 79 studies and 21,002 patients found at least one discontinuation symptom in 31 percent of people stopping an antidepressant versus 17 percent stopping placebo, with roughly 15 percent attributable to the medication.

Does TMS cause weight gain or sexual side effects?
Neither is among the risks FDA identified for this device type, which include scalp discomfort, headache, thermal injury, hearing loss and seizure. Weight and sexual function have not been studied as TMS outcomes well enough to say either way, so the honest answer is “not a recognized effect,” rather than “proven not to happen.”

Can I do TMS instead of antidepressants?
Not as a first treatment. The cleared indication is for adults with major depressive disorder who did not get satisfactory improvement from antidepressant treatment in the current episode, so TMS follows medication trials rather than replacing them. Whether you stay on a medication during TMS is your prescriber’s call.

The bottom line

Side effects end antidepressant trials all the time, and too many end in silence. There is a real list of things a prescriber can adjust, and none start with you stopping a medication on your own. If several medications have been intolerable, that belongs in a conversation about treatment that does not work through the bloodstream. TMS is one honest option there, with real risks of its own, and the reason to consider it is that it works differently, not that it works better.

Talk with us

If you are in Fort Worth or the surrounding North Texas area and what you have read here sounds familiar, we would be glad to talk it through with you. The Institute for Advanced Psychiatry is an outpatient practice at 6800 Harris Parkway, Suite 100, treating adults 18 and older. You can request an appointment or call 817-659-7344. Bring what you tried and what it did to you; that is what a treatment-refractory depression evaluation is built on.

If you are in crisis or thinking about harming yourself, please do not wait for an appointment. Call or text 988 to reach the Suicide & Crisis Lifeline, available 24/7, or go to your nearest emergency room.

Sources

1. National Institute of Mental Health. “Mental Health Medications.” 2023. https://www.nimh.nih.gov/health/topics/mental-health-medications
2. Hansen DG, Vach W, Rosholm JU, Sondergaard J, Gram LF, Kragstrup J. “Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics.” Family Practice. 2004. https://pubmed.ncbi.nlm.nih.gov/15520034/
3. U.S. National Library of Medicine, DailyMed. “ZOLOFT (sertraline hydrochloride) tablet, film coated; ZOLOFT (sertraline hydrochloride) solution, concentrate.” Label revised 8/2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fda754f6-d0f3-4dce-a17a-927d64f912f7
4. U.S. National Library of Medicine, DailyMed. “REMERON (mirtazapine) tablet, film coated; REMERONSolTab (mirtazapine) tablet, orally disintegrating.” Label revised 11/2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98ad1917-a094-44f5-a28f-a64a8cfcd887
5. U.S. Department of Veterans Affairs / Department of Defense. “VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder, Version 4.0.” 2022. https://www.healthquality.va.gov/guidelines/MH/mdd/VADoDMDDCPGFinal508.pdf
6. Rush AJ, Trivedi MH, Wisniewski SR, et al. “Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.” New England Journal of Medicine. 2006. https://pubmed.ncbi.nlm.nih.gov/16554525/
7. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. “Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis.” The Lancet Psychiatry. 2024 (see also the erratum, Lancet Psychiatry 2024;11(9):e11). https://pubmed.ncbi.nlm.nih.gov/38851198/
8. MedlinePlus, U.S. National Library of Medicine. “Sertraline.” Revised 2025. https://medlineplus.gov/druginfo/meds/a697048.html
9. Crowe M, Inder M, McCall C. “Experience of antidepressant use and discontinuation: A qualitative synthesis of the evidence.” Journal of Psychiatric and Mental Health Nursing. 2023. https://pubmed.ncbi.nlm.nih.gov/35713005/
10. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. “Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients.” Journal of Clinical Psychiatry. 2001. https://pubmed.ncbi.nlm.nih.gov/11229449/
11. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. “Antidepressant-induced sexual dysfunction.” Annals of Pharmacotherapy. 2002. https://pubmed.ncbi.nlm.nih.gov/12243609/
12. Clayton AH, El Haddad S, Iluonakhamhe JP, Ponce Martinez C, Schuck AE. “Sexual dysfunction associated with major depressive disorder and antidepressant treatment.” Expert Opinion on Drug Safety. 2014. https://pubmed.ncbi.nlm.nih.gov/25148932/
13. Jawad MY, Fatima M, Hassan U, et al. “Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature.” Human Psychopharmacology: Clinical and Experimental. 2023. https://pubmed.ncbi.nlm.nih.gov/37184083/
14. Masdrakis VG, Markianos M, Baldwin DS. “Apathy associated with antidepressant drugs: a systematic review.” Acta Neuropsychiatrica. 2023. https://pubmed.ncbi.nlm.nih.gov/36644883/
15. Ma H, Cai M, Wang H. “Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research.” Frontiers in Psychiatry. 2021. https://pubmed.ncbi.nlm.nih.gov/34970173/
16. U.S. Food and Drug Administration. “510(k) Summary – Brainsway Deep TMS System (K173540).” 2018. https://www.accessdata.fda.gov/cdrh_docs/pdf17/K173540.pdf
17. U.S. Food and Drug Administration. “De Novo Classification Request for Brainsway Deep Transcranial Magnetic Stimulation System (DEN170078) – Decision Summary.” 2018. https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170078.pdf
18. Taylor JJ, Newberger NG, Stern AP, Phillips A, Feifel D, Betensky RA, Press DZ. “Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions.” Brain Stimulation. 2021. https://pubmed.ncbi.nlm.nih.gov/34133991/
19. Institute for Advanced Psychiatry. “Price List.” Accessed 2026. https://www.psychiatryfortworth.com/price-list/

Medical disclaimer

This article is for general education and is not medical advice, a diagnosis, or a treatment recommendation for any individual. Reading it does not create a physician-patient relationship. Treatment decisions, including whether any medication or procedure is appropriate for you, should be made with a qualified clinician who knows your history. Do not start, stop, or change a psychiatric medication without talking to your prescriber. If you are experiencing a medical or mental health emergency, call 911 or 988.